Medicare Enrolled
Dr. Todd Shenkenberg, M.D.
Hematology & Oncology · Harlingen, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shenkenberg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shenkenberg? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shenkenberg
Dr. Todd Shenkenberg is a hematology & oncology in Harlingen, TX, with 19 years in practice. Based on federal Medicare data, Dr. Shenkenberg performed 140,220 Medicare services across 5,226 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shenkenberg received a total of $23,687 from 106 pharmaceutical and/or device companies across 1624 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shenkenberg is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 3% volume in TX$ $23,687 industry payments
Medicare Practice Summary
Medicare Utilization ↗140,220
Medicare services
Top 3% in TX for hematology & oncology
5,226
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,380 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 44,800 | $0 | $1 |
| Filgrastim injection (Zarxio) for white blood cells | 30,300 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 15,400 | $43 | $70 |
| Denosumab injection (Prolia/Xgeva) | 13,500 | $18 | $43 |
| Dexamethasone injection (steroid) | 6,854 | $0 | $0 |
| Blood draw (venipuncture) | 3,819 | $8 | $20 |
| Complete blood count (CBC) with differential | 3,818 | $8 | $22 |
| Comprehensive metabolic blood panel | 3,752 | $10 | $24 |
| Office visit, established patient (20-29 min) | 3,547 | $63 | $122 |
| Epoetin alfa injection (Procrit) for anemia | 3,280 | $6 | $22 |
| Drug injection, under skin or into muscle | 1,007 | $10 | $30 |
| Hospital follow-up visit, moderate complexity | 914 | $61 | $115 |
| Ceftriaxone antibiotic injection | 876 | $0 | $4 |
| Anti-nausea injection (Aloxi/palonosetron) | 830 | $1 | $31 |
| Injection of additional new drug or substance into vein | 780 | $11 | $45 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 499 | $47 | $120 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 497 | $21 | $60 |
| Injection of drug or substance into vein | 449 | $27 | $89 |
| Administration of chemotherapy into vein, 1 hour or less | 438 | $94 | $267 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 416 | $20 | $46 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 332 | $1 | $6 |
| Ferritin level test (iron stores) | 330 | $13 | $30 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 316 | $4 | $15 |
| Injection, ketorolac tromethamine, per 15 mg | 300 | $0 | $2 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 285 | $15 | $75 |
| Anti-nausea injection (ondansetron/Zofran) | 276 | $0 | $0 |
| Urinalysis with microscopic exam | 272 | $3 | $7 |
| Injection, diphenhydramine hcl, up to 50 mg | 235 | $1 | $2 |
| Thyroid stimulating hormone (TSH) test | 211 | $16 | $38 |
| PSA test (prostate cancer screening) | 195 | $18 | $41 |
| Hospital follow-up visit, high complexity | 146 | $91 | $145 |
| Administration of chemotherapy into vein, each additional hour | 143 | $20 | $60 |
| Magnesium level test | 130 | $7 | $15 |
| Initial hospital admission, high complexity | 121 | $129 | $235 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 110 | $134 | $568 |
| Carcinoembryonic antigen (cea) protein level | 109 | $19 | $42 |
| New patient office or other outpatient visit, 15-29 minutes | 96 | $49 | $125 |
| Prothrombin time test (blood clotting) | 94 | $4 | $7 |
| Administration of additional new drug or substance into vein, 1 hour or less | 90 | $49 | $130 |
| Detection test by immunoassay with direct visual observation for influenza virus | 87 | $16 | $20 |
| Thyroxine (thyroid chemical), total | 86 | $7 | $16 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 86 | $24 | $51 |
| Injection, zoledronic acid, 1 mg | 72 | $7 | $184 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 48 | $50 | $100 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 48 | $31 | $75 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 41 | $4 | $11 |
| Infusion into a vein for hydration, 31-60 minutes | 32 | $23 | $95 |
| Infusion, normal saline solution , 1000 cc | 31 | $2 | $6 |
| Flu vaccine administration | 30 | $24 | $25 |
| Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 25 | $33 | $35 |
| New patient office visit (30-44 min) | 22 | $85 | $182 |
| Hospital discharge day management, 30 minutes or less | 18 | $62 | $135 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 15 | $40 | $90 |
| Office visit, established patient (30-39 min) | 12 | $98 | $184 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
85.8% medium
13.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$23,687
Total received (2018-2024)
Avg $3,384/year across 7 years
Top 19% in TX for hematology & oncology
106
Companies
1,624
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,214 (93.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,472 (6.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,082
2023$4,095
2022$3,782
2021$3,503
2020$2,791
2019$3,270
2018$3,164
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$1,876
Novartis Pharmaceuticals Corporation
$1,740
PFIZER INC.
$1,703
Janssen Biotech, Inc.
$1,333
AstraZeneca Pharmaceuticals LP
$1,185
Amgen Inc.
$1,157
Merck Sharp & Dohme Corporation
$959
Genentech USA, Inc.
$882
Astellas Pharma US Inc
$874
GENZYME CORPORATION
$801
Seagen Inc.
$778
Merck Sharp & Dohme LLC
$670
Incyte Corporation
$570
Eisai Inc.
$555
Celgene Corporation
$545
Daiichi Sankyo Inc.
$438
EISAI INC.
$358
Bayer Healthcare Pharmaceuticals Inc.
$327
PUMA BIOTECHNOLOGY, INC.
$265
Boehringer Ingelheim Pharmaceuticals, Inc.
$254
Gilead Sciences, Inc.
$253
Regeneron Healthcare Solutions, Inc.
$246
Teva Pharmaceuticals USA, Inc.
$244
BeiGene USA, Inc.
$222
GlaxoSmithKline, LLC.
$220
Pharmacyclics LLC, An AbbVie Company
$190
Verastem, Inc.
$186
Takeda Pharmaceuticals U.S.A., Inc.
$180
SOBI, INC
$172
Puma Biotechnology, Inc.
$170
EMD Serono, Inc.
$160
Lilly USA, LLC
$159
Exelixis Inc.
$153
Bayer HealthCare Pharmaceuticals Inc.
$151
Kite Pharma, Inc.
$148
TerSera Therapeutics LLC
$146
Rigel Pharmaceuticals, Inc.
$135
Octapharma USA, Inc.
$128
Dova Pharmaceuticals
$126
Karyopharm Therapeutics Inc.
$118
ABBVIE INC.
$109
Genmab U.S., Inc.
$108
ARRAY BIOPHARMA INC
$107
AbbVie, Inc.
$105
JAZZ PHARMACEUTICALS INC.
$96
Sobi, Inc
$90
Taiho Oncology, Inc.
$90
TAIHO ONCOLOGY, INC.
$89
Pharmacosmos Therapeutics Inc.
$88
Sirtex Medical Inc
$88
AVEO Pharmaceuticals, Inc.
$84
Deciphera Pharmaceuticals Inc.
$82
Ipsen Biopharmaceuticals, Inc
$74
Janssen Pharmaceuticals, Inc
$67
Myovant Sciences Inc.
$67
AbbVie Inc.
$67
SANOFI-AVENTIS U.S. LLC
$65
Coherus Biosciences Inc.
$62
TESARO, Inc.
$60
Helsinn Therapeutics (U.S.), Inc.
$59
Jazz Pharmaceuticals Inc.
$57
Amneal Pharmaceuticals LLC
$51
Blueprint Medicines Corporation
$50
Clovis Oncology, Inc.
$50
Heron Therapeutics, Inc.
$49
ADC Therapeutics America, Inc.
$46
Kyowa Kirin, Inc.
$43
Spectrum Pharmaceuticals Inc.
$43
Sandoz Inc.
$42
Secura Bio, Inc.
$42
AMAG Pharmaceuticals, Inc.
$42
PharmaEssentia USA Corporation
$41
Immunocore Limited
$41
Agios Pharmaceuticals, Inc.
$41
Sumitomo Pharma America, Inc.
$36
Myriad Genetic Laboratories, Inc.
$32
Pharming Healthcare, Inc.
$32
MorphoSys, US Inc.
$30
CTI BioPharma Corp.
$29
Tolmar, Inc.
$27
Fennec Pharmaceuticals, Inc.
$26
Alexion Pharmaceuticals, Inc.
$26
Mirati Therapeutics, Inc.
$25
SpringWorks Therapeutics, Inc.
$23
Adaptive Biotechnologies Corporation
$22
Epizyme, Inc.,
$20
Otsuka America Pharmaceutical, Inc.
$19
Foundation Medicine, Inc.
$19
SERVIER PHARMACEUTICALS LLC
$18
Grifols USA, LLC
$18
Tactile Systems Technology Inc
$17
Janssen Scientific Affairs, LLC
$17
Array BioPharma Inc.
$16
Sebela Pharmaceuticals Inc.
$16
Pharmacyclics LLC, an AbbVie Company
$15
ViiV Healthcare Company
$15
Tempus AI, Inc
$14
Immunomedics, Inc.
$13
Melinta Therapeutics, LLC
$13
SUN PHARMACEUTICAL INDUSTRIES INC.
$12
Acrotech Biopharma LLC
$12
Aveo Pharmaceuticals, Inc.
$12
Seattle Genetics, Inc.
$11
Servier Pharmaceuticals LLC
$11
R-Pharm US LLC
$11
NOVARTIS PHARMACEUTICALS CORPORATION
$7
Top 3 companies account for 22.5% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · AVASTIN · AYVAKIT · Abraxane · Alecensa · Alphanate · Avastin · BALVERSA · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · Braftovi · CABENUVA · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · CINVANTI · COSELA · CREON · CYRAMZA · Cabometyx · Cinvanti · Columvi · Copiktra · Creon · DALVANCE · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · ERLEADA · EVENITY · Enhertu · Epkinly · Erleada · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE CDX · Fabhalta · Farydak · Flexitouch Plus · Folotyn · GAUCHER-DISEASE · GAVRETO · GAZYVA · GILOTRIF · Gazyva · HEMLIBRA · HERZUMA · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INFUGEM · INJECTAFER · INLYTA · INQOVI · Imbruvica · Ixempra · JADENU · JAKAFI · JEVTANA · Jivi · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LOKELMA · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MOTOFEN · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orbactiv · PADCEV · PANZYGA · PIQRAY · POLIVY · POTELIGEO · PRECISETUMOR · PROMACTA · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · REXULTI · ROLVEDON · RUCONEST · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SOMAVERT · SPRYCEL · SUSTOL · SUTENT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tecentriq · Tibsovo · Trodelvy · Truxima · Turalio · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · VYXEOS · Vectibix · Venclexta · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZARXIO · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $17 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
4
Per 100K population
0.9
County median income
$51,334
Nearest hospital
VHS HARLINGEN HOSPITAL COMPANY LLC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Shenkenberg is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (low-engagement, top 19%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Shenkenberg experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Shenkenberg performed 44,800 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shenkenberg receive payments from pharmaceutical companies?
Yes. Dr. Shenkenberg received a total of $23,687 from 106 companies across 1,624 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shenkenberg's costs compare to other hematology & oncologys in Harlingen?
Dr. Shenkenberg's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shenkenberg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Harlingen
Browse hematology & oncologys in Harlingen ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in TX
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in TX
Which TX hematology & oncologys receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology